These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Patent first, ask questions later: morality and biotechnology in patent law. Bagley MA William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677 [TBL] [Abstract][Full Text] [Related]
6. Patent term extension in Japan: challenges still lay ahead even after the 2011 revision. Komatani TS Pharm Pat Anal; 2013 Jan; 2(1):63-76. PubMed ID: 24236971 [TBL] [Abstract][Full Text] [Related]
7. What is your reasonable expectation of success in obtaining pharmaceutical or biotechnology patents having nonobvious claimed inventions that the courts will uphold? An overview of obviousness court decisions. Pereira DJ; Kunin SG Cold Spring Harb Perspect Med; 2014 Dec; 5(4):. PubMed ID: 25475106 [TBL] [Abstract][Full Text] [Related]
8. Inventions and Patents: A Practical Tutorial. Mehta H; Tidwell L; Liotta LA Methods Mol Biol; 2017; 1606():379-397. PubMed ID: 28502014 [TBL] [Abstract][Full Text] [Related]
9. Revocation of European patent for neural progenitors highlights patent challenges for inventions relating to human embryonic stem cells. Rigby B Expert Opin Ther Pat; 2013 Nov; 23(11):1395-8. PubMed ID: 24079708 [TBL] [Abstract][Full Text] [Related]
10. Strategies for strengthening patent protection of pharmaceutical inventions in light of federal court decisions. Pillai X; Kinney WA Curr Top Med Chem; 2010; 10(18):1929-36. PubMed ID: 20615184 [TBL] [Abstract][Full Text] [Related]
11. From the Bench to the Pharmacy: Protecting Innovation During Vaccine Development and Commercialization. Krol AC; Abu-Shaar M; Brady P Methods Mol Biol; 2016; 1404():813-834. PubMed ID: 27076339 [TBL] [Abstract][Full Text] [Related]
12. An overview of pharmaceutical cocrystals as intellectual property. Trask AV Mol Pharm; 2007; 4(3):301-9. PubMed ID: 17477544 [TBL] [Abstract][Full Text] [Related]
13. Misleading data in pharmaceutical and biological patent specifications: best mode after the America Invents Act. Laporte C; Deneke CC; Banks D Pharm Pat Anal; 2015; 4(4):247-51. PubMed ID: 26174564 [No Abstract] [Full Text] [Related]
14. The patentability of medicinal inventions related to personalized medicine in Japan. Shimbo I; Cobden A; Sumikura K Nat Biotechnol; 2005 Nov; 23(11):1367-9. PubMed ID: 16273062 [TBL] [Abstract][Full Text] [Related]
15. Using the written description requirement to limit broad patent scope, allow competition, and encourage innovation in biotechnology. Mull WC Health Matrix Clevel; 2004; 14(2):393-435. PubMed ID: 15503695 [TBL] [Abstract][Full Text] [Related]
16. Patents: a tool to bring innovation from the lab bench to the marketplace. Li ZY; Meyer W Methods Mol Biol; 2014; 1152():297-310. PubMed ID: 24744041 [TBL] [Abstract][Full Text] [Related]
17. A guide to drug discovery. Protecting your inventions: the patent system. Webber PM Nat Rev Drug Discov; 2003 Oct; 2(10):823-30. PubMed ID: 14526385 [TBL] [Abstract][Full Text] [Related]
18. Canada's Supreme Court abolishes 'promise of the patent'. Norman J; Gloor A Pharm Pat Anal; 2018 Jan; 7(1):1-5. PubMed ID: 29227204 [TBL] [Abstract][Full Text] [Related]
19. Appropriability and basicness of R&D: Identifying and characterising product and process inventions in patent data. Heinrich S; Seliger F; Wörter M PLoS One; 2022; 17(8):e0272225. PubMed ID: 35969608 [TBL] [Abstract][Full Text] [Related]
20. Patent border wars: defining the boundary between scientific discoveries and patentable inventions. Holman CM Trends Biotechnol; 2007 Dec; 25(12):539-43. PubMed ID: 17983675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]